Identification of promising biomarkers for central nervous system lymphoma

Findings from a prospective study have identified 2 potentially useful biomarkers for central nervous system lymphoma (CNSL). Chemokine CXCL13 may be valuable as a prognostic marker, while both CXCL9 and CXCL13 may be useful to monitor therapy.